BON Develops AI Bio-Electronic Mask and Launches Joint Lab for Natural Ingredients

Bon Natural Life Limited (Nasdaq: BON) announced development of an AI-enabled flexible bio-electronic anti-aging facial mask using apple polyphenols as the core active ingredient. The company completed sample development and preliminary internal performance evaluations that exceeded internal benchmarks and plans expanded third-party clinical testing. The product targets the global anti-aging market exceeding $100 billion.

Serving as the core natural active ingredient of this product, apple polyphenols are extracted from premium apple pomace and contain polyphenolic compounds such as proanthocyanidins and quercetin. These compounds are widely studied for their antioxidant, anti-inflammatory, and photoprotective properties. Published research indicates that apple polyphenols may help inhibit collagen degradation, reduce UV-induced oxidative stress, and support melanin metabolism, contributing to visible improvements in skin firmness, brightness, and overall appearance.

Powered by its AI-enabled flexible bio-electronic platform, BON's mask combines flexible electronic materials with smart controlled-release technology to enhance transdermal penetration of the active ingredients. This approach is designed to address the absorption limitations typically associated with conventional topical skincare products.

The company has completed sample development and preliminary internal performance evaluations of the AI-powered flexible bio-electronic mask incorporating apple polyphenols. Across key performance indicators — including the appearance of fine lines, skin firmness, UV-related skin stress, and overall brightness — the initial results have exceeded internal benchmarks. In the next phase, the company plans to initiate expanded third-party clinical testing while advancing product finalization and optimizing large-scale manufacturing processes.

Separately, BON announced the establishment of the BON & Pilot Joint Laboratory for Natural Ingredients and Bio-Manufacturing. The Joint Laboratory was inaugurated on December 18, 2025 through a collaboration between the company's domestic operating subsidiary, Xi'an App-Chem Bio-Tech Co., Ltd., and Shaanxi Chang'an Pilot Life Science Industry Innovation Center Co., Ltd.

The Joint Laboratory will focus on the research and development of bio-manufactured natural active ingredients for use in functional foods and personal care products. Through the integration of fermentation-based biosynthesis, natural compound isolation, and artificial intelligence-enabled process optimization, the Joint Laboratory is intended to support the company's efforts to improve production efficiency, supply reliability, and environmental sustainability compared to traditional plant-based extraction methods.

Chang'an Pilot, established in 2022, provides laboratory infrastructure and research services focused on life sciences and artificial intelligence-enabled manufacturing technologies. The chairman stated that the establishment of the Joint Laboratory will strengthen research capabilities and create meaningful collaboration between the respective teams, supporting continued efforts to develop scalable, high-quality natural ingredients and advance long-term growth strategy.

Founded in 2006, BON operates in the development, manufacturing, and commercialization of natural active ingredients for applications in health and personal care products. The company's product portfolio includes plant-derived extracts, functional food ingredients, and personal care actives. BON serves customers in China, North America, the European Union, Japan, South Korea, and other international markets.

BON possesses technical capabilities in natural ingredient extraction, separation, and biosynthesis, supported by a proprietary artificial intelligence-enabled bio-manufacturing research and development platform designed to integrate data analytics and process engineering for scalable production.